Pluristem Therapeutics, Inc. was a big mover last session, as the company saw its shares rise over 7% on the day. This rally higher can be attributable to solid volume too with far more shares changing hands than in a normal session.
Shares of Pluristem Therapeutics Inc. (NASDAQ:PSTI) rose by 3.93% in the past week and 4.3% for the past 4 weeks. For the past week, the counter has outperformed the S&P 500 by 1.87% and the outperformance increases to 0.44% for the past 4 weeks.
After all, the Zacks Earnings ESP compares the most accurate estimate to the broad consensus, looking to find stocks that have seen big revisions as of late, suggesting that analysts have recently become more bullish on the company's earnings prospects.
Pluristem Therapeutics Inc. (NASDAQ:PSTI) Update based on the information released on Wednesday, Feb 18th , Pluristem Therapeutics announced the positive results of a recently completed trial conducted by the U.S.
Pluristem Therapeutics Inc. (NASDAQ:PSTI): 3 analysts have set the short term price target of Pluristem Therapeutics Inc. (NASDAQ:PSTI) at $4. The standard deviation of short term price target has been estimated at $1, implying that the actual price ...